183 related articles for article (PubMed ID: 21224468)
1. ETV6/RUNX1-positive relapses evolve from an ancestral clone and frequently acquire deletions of genes implicated in glucocorticoid signaling.
Kuster L; Grausenburger R; Fuka G; Kaindl U; Krapf G; Inthal A; Mann G; Kauer M; Rainer J; Kofler R; Hall A; Metzler M; Meyer LH; Meyer C; Harbott J; Marschalek R; Strehl S; Haas OA; Panzer-Grümayer R
Blood; 2011 Mar; 117(9):2658-67. PubMed ID: 21224468
[TBL] [Abstract][Full Text] [Related]
2. Genetic alterations in glucocorticoid signaling pathway components are associated with adverse prognosis in children with relapsed ETV6/RUNX1-positive acute lymphoblastic leukemia.
Grausenburger R; Bastelberger S; Eckert C; Kauer M; Stanulla M; Frech C; Bauer E; Stoiber D; von Stackelberg A; Attarbaschi A; Haas OA; Panzer-Grümayer R
Leuk Lymphoma; 2016 May; 57(5):1163-73. PubMed ID: 26327566
[TBL] [Abstract][Full Text] [Related]
3. Copy number genome alterations are associated with treatment response and outcome in relapsed childhood ETV6/RUNX1-positive acute lymphoblastic leukemia.
Bokemeyer A; Eckert C; Meyr F; Koerner G; von Stackelberg A; Ullmann R; Türkmen S; Henze G; Seeger K
Haematologica; 2014 Apr; 99(4):706-14. PubMed ID: 24241490
[TBL] [Abstract][Full Text] [Related]
4. The correlation pattern of acquired copy number changes in 164 ETV6/RUNX1-positive childhood acute lymphoblastic leukemias.
Lilljebjörn H; Soneson C; Andersson A; Heldrup J; Behrendtz M; Kawamata N; Ogawa S; Koeffler HP; Mitelman F; Johansson B; Fontes M; Fioretos T
Hum Mol Genet; 2010 Aug; 19(16):3150-8. PubMed ID: 20513752
[TBL] [Abstract][Full Text] [Related]
5. Excellent prognosis of late relapses of ETV6/RUNX1-positive childhood acute lymphoblastic leukemia: lessons from the FRALLE 93 protocol.
Gandemer V; Chevret S; Petit A; Vermylen C; Leblanc T; Michel G; Schmitt C; Lejars O; Schneider P; Demeocq F; Bader-Meunier B; Bernaudin F; Perel Y; Auclerc MF; Cayuela JM; Leverger G; Baruchel A;
Haematologica; 2012 Nov; 97(11):1743-50. PubMed ID: 22580999
[TBL] [Abstract][Full Text] [Related]
6. Clonal origins of relapse in ETV6-RUNX1 acute lymphoblastic leukemia.
van Delft FW; Horsley S; Colman S; Anderson K; Bateman C; Kempski H; Zuna J; Eckert C; Saha V; Kearney L; Ford A; Greaves M
Blood; 2011 Jun; 117(23):6247-54. PubMed ID: 21482711
[TBL] [Abstract][Full Text] [Related]
7. Clonal variation of the immunogenotype in relapsed ETV6/RUNX1-positive acute lymphoblastic leukemia indicates subclone formation during early stages of leukemia development.
Peham M; Konrad M; Harbott J; König M; Haas OA; Panzer-Grümayer ER
Genes Chromosomes Cancer; 2004 Feb; 39(2):156-60. PubMed ID: 14695996
[TBL] [Abstract][Full Text] [Related]
8. ETV6/RUNX1 fusion at diagnosis and relapse: some prognostic indications.
Martineau M; Jalali GR; Barber KE; Broadfield ZJ; Cheung KL; Lilleyman J; Moorman AV; Richards S; Robinson HM; Ross F; Harrison CJ
Genes Chromosomes Cancer; 2005 May; 43(1):54-71. PubMed ID: 15704129
[TBL] [Abstract][Full Text] [Related]
9. Abnormalities of the der(12)t(12;21) in ETV6-RUNX1 acute lymphoblastic leukemia.
Al-Shehhi H; Konn ZJ; Schwab CJ; Erhorn A; Barber KE; Wright SL; Gabriel AS; Harrison CJ; Moorman AV
Genes Chromosomes Cancer; 2013 Feb; 52(2):202-13. PubMed ID: 23077088
[TBL] [Abstract][Full Text] [Related]
10. Determination of ETV6-RUNX1 genomic breakpoint by next-generation sequencing.
Jin Y; Wang X; Hu S; Tang J; Li B; Chai Y
Cancer Med; 2016 Feb; 5(2):337-51. PubMed ID: 26711002
[TBL] [Abstract][Full Text] [Related]
11. ETV6/RUNX1-like acute lymphoblastic leukemia: A novel B-cell precursor leukemia subtype associated with the CD27/CD44 immunophenotype.
Zaliova M; Kotrova M; Bresolin S; Stuchly J; Stary J; Hrusak O; Te Kronnie G; Trka J; Zuna J; Vaskova M
Genes Chromosomes Cancer; 2017 Aug; 56(8):608-616. PubMed ID: 28395118
[TBL] [Abstract][Full Text] [Related]
12. Outcome and Prognostic Factors for
Lee JW; Kim SK; Jang PS; Chung NG; Jeong DC; Kim M; Cho B; Kim HK
Cancer Res Treat; 2017 Apr; 49(2):446-453. PubMed ID: 27506214
[TBL] [Abstract][Full Text] [Related]
13. Late relapses evolve from slow-responding subclones in t(12;21)-positive acute lymphoblastic leukemia: evidence for the persistence of a preleukemic clone.
Konrad M; Metzler M; Panzer S; Ostreicher I; Peham M; Repp R; Haas OA; Gadner H; Panzer-Grumayer ER
Blood; 2003 May; 101(9):3635-40. PubMed ID: 12506024
[TBL] [Abstract][Full Text] [Related]
14. Acquisition of genome-wide copy number alterations in monozygotic twins with acute lymphoblastic leukemia.
Bateman CM; Colman SM; Chaplin T; Young BD; Eden TO; Bhakta M; Gratias EJ; van Wering ER; Cazzaniga G; Harrison CJ; Hain R; Ancliff P; Ford AM; Kearney L; Greaves M
Blood; 2010 Apr; 115(17):3553-8. PubMed ID: 20061556
[TBL] [Abstract][Full Text] [Related]
15. Clonal origins of ETV6-RUNX1⁺ acute lymphoblastic leukemia: studies in monozygotic twins.
Alpar D; Wren D; Ermini L; Mansur MB; van Delft FW; Bateman CM; Titley I; Kearney L; Szczepanski T; Gonzalez D; Ford AM; Potter NE; Greaves M
Leukemia; 2015 Apr; 29(4):839-46. PubMed ID: 25388957
[TBL] [Abstract][Full Text] [Related]
16. Pathogenesis of ETV6/RUNX1-positive childhood acute lymphoblastic leukemia and mechanisms underlying its relapse.
Sun C; Chang L; Zhu X
Oncotarget; 2017 May; 8(21):35445-35459. PubMed ID: 28418909
[TBL] [Abstract][Full Text] [Related]
17. High sensitivity and clonal stability of the genomic fusion as single marker for response monitoring in ETV6-RUNX1-positive acute lymphoblastic leukemia.
Hoffmann J; Krumbholz M; Gutiérrez HP; Fillies M; Szymansky A; Bleckmann K; Zur Stadt U; Köhler R; Kuiper RP; Horstmann M; von Stackelberg A; Eckert C; Metzler M
Pediatr Blood Cancer; 2019 Aug; 66(8):e27780. PubMed ID: 31034759
[TBL] [Abstract][Full Text] [Related]
18. [Heterogeneity and clonal evolution in pediatric ETV6-RUNX1(+) acute lymphoblastic leukemia by quantitative multigene fluorescence in situ hybridization].
Zhang L; Hu LP; Liu XM; Guo Y; Yang WY; Zhang JY; Liu F; Liu TF; Wang SC; Chen XJ; Ruan M; Qi BQ; Chang LX; Chen YM; Zou Y; Zhu XF
Zhonghua Xue Ye Xue Za Zhi; 2017 Jul; 38(7):586-591. PubMed ID: 28810325
[No Abstract] [Full Text] [Related]
19. SYK Targeting Represents a Potential Therapeutic Option for Relapsed Resistant Pediatric
Serafin V; Porcù E; Cortese G; Mariotto E; Veltri G; Bresolin S; Basso G; Accordi B
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31817853
[TBL] [Abstract][Full Text] [Related]
20. Role of the erythropoietin receptor in ETV6/RUNX1-positive acute lymphoblastic leukemia.
Inthal A; Krapf G; Beck D; Joas R; Kauer MO; Orel L; Fuka G; Mann G; Panzer-Grümayer ER
Clin Cancer Res; 2008 Nov; 14(22):7196-204. PubMed ID: 19010836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
